Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

170.18 -0.02 (-0.01%)
Official Closing Price Updated: 4:00 PM EDT, Aug 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,823,343
Open 170.54
Bid (Size) 169.44 (1)
Ask (Size) 170.70 (1)
Prev. Close 170.20
Today's Range 169.73 - 171.12
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Why Is Novavax (NVAX) Stock Plunging 30%?
Shares of NVAX stock are falling after the company cut its revenue outlook in half and delivered a poor Q2 earnings report. 
Via InvestorPlace

Performance

YTD
-0.79%
-0.79%
1 Month
-4.58%
-4.58%
3 Month
-4.03%
-4.03%
6 Month
-0.51%
-0.51%
1 Year
-2.03%
-2.03%

More News

Read More
3 Dividend Stocks to Buy to Beat Runaway Inflation
Via InvestorPlace
The 3 Best Vanguard Funds to Buy in August
Via InvestorPlace
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
3 Blue-Chip Stocks With Rock-Solid Dividends
Via Talk Markets
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Via MarketBeat
Johnson & Johnson Whale Trades Spotted
Via Benzinga
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
Via Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Via Benzinga
Top 5 High-Quality Dividend Growth “Forever Stocks” To Buy
Via Talk Markets
Best Stocks To Hold For The Recession
Via Talk Markets
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
Via InvestorPlace
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Via Benzinga
Benzinga Before The Bell: Apple's Latest Move For Self-Driving Car Project, Monkeypox Is A National Emergency, Spirit-Jet Blue Merger And Other Top Financial Stories Thursday, July 28
Via Benzinga
Allergan To End Around 3,000 Opioid Lawsuits With Over $2B In Settlement: Report
Via Benzinga
Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2
Via Benzinga
7 Large-Cap Stocks to Buy on the Dip
Via InvestorPlace
JNJ Stock Alert: What to Know as Johnson & Johnson Releases Clinical Trial Data
Via InvestorPlace
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
Via FinancialNewsMedia
Exposures COVID-19 Product Safety
Follow Nancy Pelosi and Watch These 8 Stocks That Lawmakers Are Buying
Via InvestorPlace
Johnson & Johnson Whale Trades For July 25
Via Benzinga
As Snap Spooks Market, Here Are The Hits & Misses Of Q2 Reporting Season
Via Benzinga
MarketBeat: Week in Review 7/18 – 7/22
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.